Hepatitis C in drug addicts: access and treatment compliance.

Detalhes bibliográficos
Autor(a) principal: Sarmento E Castro, Rui
Data de Publicação: 2011
Outros Autores: Valente, Cristina, Ramos, José Presa, Almeida, José Rocha, Marinho, Rui Tato, Branco, Teresa, Andrade, Sofia, Macedo, Ana
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445
Resumo: Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal.
id RCAP_d2bb570fbc7177724dfed1a4b521a827
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/1445
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Hepatitis C in drug addicts: access and treatment compliance.Hepatite C em toxicodependentes: acompanhamento e acesso à terapêutica.Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal.Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal.Ordem dos Médicos2011-12-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445oai:ojs.www.actamedicaportuguesa.com:article/1445Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-92Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-921646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445/1033Sarmento E Castro, RuiValente, CristinaRamos, José PresaAlmeida, José RochaMarinho, Rui TatoBranco, TeresaAndrade, SofiaMacedo, Anainfo:eu-repo/semantics/openAccess2022-12-20T10:57:53Zoai:ojs.www.actamedicaportuguesa.com:article/1445Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:17:07.859677Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Hepatitis C in drug addicts: access and treatment compliance.
Hepatite C em toxicodependentes: acompanhamento e acesso à terapêutica.
title Hepatitis C in drug addicts: access and treatment compliance.
spellingShingle Hepatitis C in drug addicts: access and treatment compliance.
Sarmento E Castro, Rui
title_short Hepatitis C in drug addicts: access and treatment compliance.
title_full Hepatitis C in drug addicts: access and treatment compliance.
title_fullStr Hepatitis C in drug addicts: access and treatment compliance.
title_full_unstemmed Hepatitis C in drug addicts: access and treatment compliance.
title_sort Hepatitis C in drug addicts: access and treatment compliance.
author Sarmento E Castro, Rui
author_facet Sarmento E Castro, Rui
Valente, Cristina
Ramos, José Presa
Almeida, José Rocha
Marinho, Rui Tato
Branco, Teresa
Andrade, Sofia
Macedo, Ana
author_role author
author2 Valente, Cristina
Ramos, José Presa
Almeida, José Rocha
Marinho, Rui Tato
Branco, Teresa
Andrade, Sofia
Macedo, Ana
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sarmento E Castro, Rui
Valente, Cristina
Ramos, José Presa
Almeida, José Rocha
Marinho, Rui Tato
Branco, Teresa
Andrade, Sofia
Macedo, Ana
description Currently, hepatitis C is a serious public health problem. It is estimated that there are 180 million people with chronic infection by hepatitis C virus (HCV) worldwide and that the prevalence of this infection in the Portuguese population ranges between 1 and 1.5%. In Portugal, there are neither up-to-date guidelines for treatment, nor recommendations for the diagnosis and management of patients with HCV and, in particular, for the endovenous drug users. The present article gathers consensus information regarding clinical practice and suggests some guidelines to the management and treatment accessibility of drug addicted patients with chronic infection by HCV, in Portugal.
publishDate 2011
dc.date.none.fl_str_mv 2011-12-29
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445
oai:ojs.www.actamedicaportuguesa.com:article/1445
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/1445
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/1445/1033
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-92
Acta Médica Portuguesa; Vol. 24 (2011): Suplemento 2; 483-92
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130624651427840